New strategies for cancer immunotherapy: Targeting regulatory T cells

Abstract

The immunosuppressive action of regulatory T (Treg) cells is one mechanism attributed to the limited success of cancer immunotherapies with checkpoint blockers. Two recent studies report distinct transcriptional profiles of tumor-infiltrating Tregcells and expression of specific molecules, suggesting novel strategies to overcome resistance to cancer immunotherapy.